This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guasch, G.
Right arrow Articles by Pébusque, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guasch, G.
Right arrow Articles by Pébusque, M.-J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2001, p. 8129-8142, Vol. 21, No. 23
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.23.8129-8142.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways

Géraldine Guasch, Vincent Ollendorff,dagger Jean-Paul Borg, Daniel Birnbaum, and Marie-Josèphe Pébusque*

Laboratoire d'Oncologie Moléculaire, INSERM U 119, IFR 57, Marseille, France

Received 2 April 2001/Returned for modification 25 May 2001/Accepted 20 August 2001

The FOP-fibroblast growth factor receptor 1 (FGFR1) fusion protein is expressed as a consequence of a t(6;8) (q27;p12) translocation associated with a stem cell myeloproliferative disorder with lymphoma, myeloid hyperplasia and eosinophilia. In the present report, we show that the fusion of the leucine-rich N-terminal region of FOP to the catalytic domain of FGFR1 results in conversion of murine hematopoietic cell line Ba/F3 to factor-independent cell survival via an antiapoptotic effect. This survival effect is dependent upon the constitutive tyrosine phosphorylation of FOP-FGFR1. Phosphorylation of STAT1 and of STAT3, but not STAT5, is observed in cells expressing FOP-FGFR1. The survival function of FOP-FGFR1 is abrogated by mutation of the phospholipase C gamma binding site. Mitogen-activated protein kinase (MAPK) is also activated in FOP-FGFR1-expressing cells and confers cytokine-independent survival to hematopoietic cells. These results demonstrate that FOP-FGFR1 is capable of protecting cells from apoptosis by using the same effectors as the wild-type FGFR1. Furthermore, we show that FOP-FGFR1 phosphorylates phosphatidylinositol 3 (PI3)-kinase and AKT and that specific inhibitors of PI3-kinase impair its ability to promote cell survival. In addition, FOP-FGFR1-expressing cells show constitutive phosphorylation of the positive regulator of translation p70S6 kinase; this phosphorylation is inhibited by PI3-kinase and mTOR (mammalian target of rapamycin) inhibitors. These results indicate that translation control is important to mediate the cell survival effect induced by FOP-FGFR1. Finally, FOP-FGFR1 protects cells from apoptosis by survival signals including BCL2 overexpression and inactivation of caspase-9 activity. Elucidation of signaling events downstream of FOP-FGFR1 constitutive activation provides insight into the mechanism of leukemogenesis mediated by this oncogenic fusion protein.

* Corresponding author. Present address: INSERM-EMI 0116, Parc Scientifique et Technologique de Luminy, B.P. 172, 13276 Marseille Cedex 09, France. Phone: 33 4 91 82 75 42. Fax: 33 4 91 82 60 83. E-mail: pebusque{at}inserm-adr.univ-mrs.fr.

dagger Present address: Institut méditerranéen de recherche en nutrition, Marseille, France.

Molecular and Cellular Biology, December 2001, p. 8129-8142, Vol. 21, No. 23
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.23.8129-8142.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Dong, S., Kang, S., Gu, T.-L., Kardar, S., Fu, H., Lonial, S., Khoury, H. J., Khuri, F., Chen, J. (2007). 14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110: 360-369 [Abstract] [Full Text]  
  • Gu, T.-L., Goss, V. L., Reeves, C., Popova, L., Nardone, J., MacNeill, J., Walters, D. K., Wang, Y., Rush, J., Comb, M. J., Druker, B. J., Polakiewicz, R. D. (2006). Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia. Blood 108: 4202-4204 [Abstract] [Full Text]  
  • Yan, X., Habedanck, R., Nigg, E. A. (2006). A Complex of Two Centrosomal Proteins, CAP350 and FOP, Cooperates with EB1 in Microtubule Anchoring. Mol. Biol. Cell 17: 634-644 [Abstract] [Full Text]  
  • Delaval, B., Letard, S., Lelievre, H., Chevrier, V., Daviet, L., Dubreuil, P., Birnbaum, D. (2005). Oncogenic Tyrosine Kinase of Malignant Hemopathy Targets the Centrosome. Cancer Res. 65: 7231-7240 [Abstract] [Full Text]  
  • Recher, C., Beyne-Rauzy, O., Demur, C., Chicanne, G., Dos Santos, C., Mas, V. M.-D., Benzaquen, D., Laurent, G., Huguet, F., Payrastre, B. (2005). Antileukemic activity of rapamycin in acute myeloid leukemia. Blood 105: 2527-2534 [Abstract] [Full Text]  
  • Maeda, T., Yagasaki, F., Ishikawa, M., Takahashi, N., Bessho, M. (2005). Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood 105: 2115-2123 [Abstract] [Full Text]  
  • Chen, J., DeAngelo, D. J., Kutok, J. L., Williams, I. R., Lee, B. H., Wadleigh, M., Duclos, N., Cohen, S., Adelsperger, J., Okabe, R., Coburn, A., Galinsky, I., Huntly, B., Cohen, P. S., Meyer, T., Fabbro, D., Roesel, J., Banerji, L., Griffin, J. D., Xiao, S., Fletcher, J. A., Stone, R. M., Gilliland, D. G. (2004). PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc. Natl. Acad. Sci. USA 101: 14479-14484 [Abstract] [Full Text]  
  • Heath, C., Cross, N. C. P. (2004). Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1. J. Biol. Chem. 279: 6666-6673 [Abstract] [Full Text]  
  • Guasch, G., Delaval, B., Arnoulet, C., Xie, M.-J., Xerri, L., Sainty, D., Birnbaum, D., Pebusque, M.-J. (2004). FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice. Blood 103: 309-312 [Abstract] [Full Text]  
  • Baumann, H., Kunapuli, P., Tracy, E., Cowell, J. K. (2003). The Oncogenic Fusion Protein-tyrosine Kinase ZNF198/Fibroblast Growth Factor Receptor-1 Has Signaling Function Comparable with Interleukin-6 Cytokine Receptors. J. Biol. Chem. 278: 16198-16208 [Abstract] [Full Text]  
  • Charest, A., Kheifets, V., Park, J., Lane, K., McMahon, K., Nutt, C. L., Housman, D. (2003). Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma. Proc. Natl. Acad. Sci. USA 100: 916-921 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»